Zepbound dosage chart: the dose schedule on the FDA label
The Zepbound label (revised 8/2026) starts treatment at 2.5 mg injected under the skin once weekly for 4 weeks, a dose for starting treatment that is not approved for maintenance, then 5 mg once weekly. The dose may then be increased in 2.5 mg increments after at least 4 weeks on the current dose. The maintenance dose is 5 mg, 10 mg or 15 mg once weekly for weight reduction, or 10 mg or 15 mg for obstructive sleep apnea, and the maximum is 15 mg once weekly.
Starting dose and dose steps
From section 2.1 of the label, "Recommended Dose Escalation Schedule", for all approved uses. The label says to follow this escalation to reduce the risk of gastrointestinal adverse reactions.
| Step | Weekly dose | Label wording |
|---|---|---|
| Starting dose | 2.5 mg | For 4 weeks. The 2.5 mg dosage is for treatment initiation and is not approved as a maintenance dosage |
| Second step | 5 mg | After 4 weeks |
| Further increases | In 2.5 mg increments | The dosage may be increased after at least 4 weeks on the current dose |
Maintenance and maximum doses
From section 2.2, "Recommended Maintenance and Maximum Dosage".
| Use | What the label says |
|---|---|
| Weight reduction and long-term maintenance | 5 mg, 10 mg or 15 mg injected subcutaneously once weekly |
| Obstructive sleep apnea (OSA) | 10 mg or 15 mg injected subcutaneously once weekly |
| Maximum, all uses | 15 mg once weekly |
Pen, KwikPen and vial strengths
From section 3, "Dosage Forms and Strengths". Single-dose pens and vials hold one dose. Multi-dose vials and single-patient-use KwikPens hold 4 doses each: the vial column shows each dose volume with the total strength of the vial in brackets, and the KwikPen column the total strength of the pen.
| Dose | Single-dose pen or vial | Multi-dose vial | KwikPen |
|---|---|---|---|
| 2.5 mg | 2.5 mg/0.5 mL | 2.5 mg/0.6 mL (10 mg/2.4 mL) | 10 mg/2.4 mL |
| 5 mg | 5 mg/0.5 mL | 5 mg/0.6 mL (20 mg/2.4 mL) | 20 mg/2.4 mL |
| 7.5 mg | 7.5 mg/0.5 mL | 7.5 mg/0.6 mL (30 mg/2.4 mL) | 30 mg/2.4 mL |
| 10 mg | 10 mg/0.5 mL | 10 mg/0.6 mL (40 mg/2.4 mL) | 40 mg/2.4 mL |
| 12.5 mg | 12.5 mg/0.5 mL | 12.5 mg/0.6 mL (50 mg/2.4 mL) | 50 mg/2.4 mL |
| 15 mg | 15 mg/0.5 mL | 15 mg/0.6 mL (60 mg/2.4 mL) | 60 mg/2.4 mL |
Where this chart comes from
Every dose and strength above is copied from the US prescribing information for Zepbound (tirzepatide) by Eli Lilly and Company: Zepbound (tirzepatide) injection: prescribing information, Medication Guide and Instructions for Use, revised 8/2026 (DailyMed version 40, published 2 September 2026), sections 2 and 3. We read it on and update this page when the label changes.
Section 2 of the Zepbound label also covers tolerability when choosing a maintenance dose, missed doses and administration for each presentation. Those are instructions for your prescriber and are not repeated here; read them in the label, the Medication Guide or the Instructions for Use, or ask your pharmacist.
Compounded tirzepatide is not Zepbound
Compounded tirzepatide is not Zepbound. It is not FDA-approved, and this label and chart do not apply to it. If your prescription is a compounded vial, the tirzepatide calculator does the arithmetic from the amount your prescriber wrote to mL and syringe units, and the units to mg calculator works it the other way round. Check the result with your pharmacist.
Keeping a record of your dose steps
A log makes it easy to see which step of the schedule you are on and how you felt at each one. Record the dose your prescriber set, the date each new dose started, the strength printed on the pen or carton, and any side effects with their dates. The Zepbound tracker page lists what to log for each Zepbound injection, and how to track tirzepatide covers every tirzepatide brand. The GLP-1 tracker template is a free printable or CSV version.
PeptideMate keeps the same record on Android, iPhone, iPad and Mac, or in the browser with the free online peptide tracker. It records the dose you enter and never suggests one.
Zepbound dosage chart questions
What is the starting dose on the Zepbound label?
The label gives a starting dosage of 2.5 mg injected subcutaneously once weekly for 4 weeks, for all approved uses, and says the 2.5 mg dosage is for treatment initiation and is not approved as a maintenance dosage. Your prescriber decides your dose.
What is the maximum Zepbound dose on the label?
The label gives a maximum of 15 mg injected subcutaneously once weekly for all approved uses.
Can I use this chart to change my dose?
No. It shows what the label prints, for reference. Your prescriber sets your dose and decides when it changes; ask them or your pharmacist about anything on this page.
Sources
- Zepbound (tirzepatide) injection: prescribing information, Medication Guide and Instructions for Use, Eli Lilly and Company, via DailyMed (US National Library of Medicine); prescribing information revised 8/2026, DailyMed version 40 published 2 September 2026. Used for: Every dose and strength on this page: sections 2 (Dosage and Administration) and 3 (Dosage Forms and Strengths).
- FDA's concerns with unapproved GLP-1 drugs used for weight loss, US Food and Drug Administration. Used for: Compounded drugs are not FDA-approved.
Other label dosage charts
- Ozempic dosage chartStarting dose, dose steps, maintenance and maximum doses and pen strengths from the Ozempic label.
- Wegovy dosage chartWeekly injection steps, maintenance doses by use, daily tablet steps and strengths from the Wegovy label.
- Mounjaro dosage chartStarting dose, 2.5 mg steps, maximum doses and every pen, KwikPen and vial strength from the Mounjaro label.
Reference only: this page reproduces the dose schedule on the FDA label and does not recommend Zepbound, a dose or a schedule. See the medical disclaimer.